FDA Recommends Approval of Vaccine to Prevent RSV in Infants through Maternal Immunization

Upcoming Events

The Kansas Association of Risk and Quality Management was created to promote the delivery of quality health care and the practice of risk management in Kansas health care facilities. Membership includes risk and quality management professionals in health care facilities or health-related organizations.

Educational Webinar: How Do Your Hospital Finances Measure Up? – May 2

Join Healthworks and KHA for an educational session at 2:00 p.m. on May 2 to learn how to utilize QHis financial benchmarking tool effectively. Shannan Flach, vice president health care finance and reimbursement and Sally Othmer, vice president data and strategic analytics will be joined by Wes Garrison, founder, Databasically to walk through the tool including the easy-upload process, reviewing the QHi financial measures available and to demonstrating how to run and schedule reports.

Opioid Educational Webinar: Partnering to Increase Access to SUD Treatment – May 3

Please join us on May 3 to hear how hospitals and communities are partnering to increase access to substance use disorder treatment and harm reduction. The program has been approved for 1.0 contact hours of continuing nursing education and pending approval for 1.0 contact hours of continuing pharmacy education. There is no charge to attend as this program is funded through a grant from our partners at DCCCA.

AHA Health Equity Conference - Driving Change Together -- May 7-9

Long-standing health care disparities and inequities persist. Systemic drivers such as structural racism and economic disadvantages have resulted in disproportionate health outcomes across different patient populations. Education, safe and affordable housing, transportation and nutritious food access all have a significant impact on the quality and quantity of an individuals life and overall health.

National Hospital Week - May 12-18

National Hospital Week is an opportunity to highlight our hospitals, health systems and health care workers and the innovative ways they are supporting and connected to their community.

Current Report Articles

‹‹ Back To List

FDA Recommends Approval of Vaccine to Prevent RSV in Infants through Maternal Immunization

(May 26, 2023) – On May 18, the Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee voted to recommend the FDA approve Pfizer's respiratory syncytial virus prefusion F vaccine candidate for maternal immunization in the third trimester to prevent RSV in infants from birth up to six months of age. The committee voted 14 to zero on effectiveness and ten to four on safety. The vaccine candidate is currently under FDA review for the prevention of medically attended lower respiratory tract disease and severe MA-LRTD caused by RSV in infants from birth up to six months of age by active immunization of pregnant individuals. The FDA's decision on the potential approval of RSVpreF for the prevention of MA-LRTD and severe MA-LRTD caused by RSV in infants by active immunization of pregnant individuals is expected in August 2023.
--Karen Braman

‹‹ Back To List

Communications

Upcoming Events

Recent News